News/ News/ Oncology Junshi plans filings after toripalimab hits target in upper throat cancer Richard Staines cancer, immunotherapy, Junshi, nasopharyngeal cancer 0 Comment China’s Junshi Biosciences has said it plans filings for a new cancer immunotherapy after its toripalimab outperformed standard Share X Junshi plans filings after toripalimab hits target in upper throat cancer https://pharmaphorum.com/news/junshi-plans-filings-after-toripalimab-hits-target-in-upper-throat-cancer/
cancer, immunotherapy, Junshi, nasopharyngeal cancer
0 Comment
